A common copper supplement form that supports immune function, iron metabolism, and connective tissue. Provides copper for enzyme function, iron metabolism, connective tissue formation, and antioxidant defense. Essential for making red blood cells and maintaining nerve function.
Reviewed March 2026
Source: NIH ODS + Klevay 2000 review
These words describe the research, not the molecule's worth. Research strength is how much work stands behind one claim, and it is never a product score.
A pairing appears on this page only when a trial gave both ingredients together and measured the result. Copper Sulfate has none that clears that bar.
Stitching two separate single-ingredient studies into a pairing is the one thing this engine will not do. When a study of the combination itself holds up at source, it lands here with its citation.
No invented synergy. Where actives were studied on their own rather than together, the record shows each on its own evidence, never a combined effect no trial measured.
Research strength. Research strength says how much work stands behind the combination. It is never a product score.
Independent record. Every finding is cited to a named trial, dated, and never written by the brand.
20 pairings are live across the library today. Checked 20 July 2026.
No study gave these as a pair, so they are not in the card above. But the reason they belong together is settled biochemistry, not a guess, so it is worth knowing.
Zinc raises enterocyte metallothionein, which binds copper preferentially and keeps it from crossing into circulation. Copper sulfate is the historical form used to balance zinc-forward products.
Continued zinc intake in any salt form suppresses copper uptake through metallothionein induction. The ratio between the two is what a formula review should read.
Sulfate is only the counter-ion, so elemental copper from both entries adds. Copper has a narrow usable range, which makes double counting consequential.
Copper-dependent hephaestin and ceruloplasmin oxidise ferrous iron to the ferric form that transferrin carries. Iron movement out of the enterocyte and the liver depends on copper being present.
Ascorbate reduces cupric copper from sulfate to the cuprous state, lowering absorption and encouraging Fenton chemistry with any free copper. Inorganic copper salts are the most exposed to this interaction.
With dietary sulfur present, molybdenum forms thiomolybdates that bind copper and pull it out of circulation. Copper sulfate itself supplies part of that sulfur.
Inorganic copper salts need gastric acid to dissolve and ionise before absorption. Carbonate raises stomach pH, which reduces how much copper goes into solution.
Copper and manganese share divalent metal transporter 1 at the brush border. Inorganic salts depend on that transporter most, so competition is more visible with sulfate.
Tyrosinase carries two active-site copper atoms and acts directly on tyrosine to form pigment. Copper is the metal that makes the reaction possible.
Phytate binds ionic copper in the gut lumen, and phytase releases it by cleaving the phosphate groups. Simple copper salts are the forms most affected by phytate.
Glutathione is the first ligand that binds newly absorbed copper inside the cell and hands it to the copper chaperones. Thiol status is part of how ionic copper is handled once inside.
Ceruloplasmin and its membrane counterpart hephaestin are copper-dependent ferroxidases that oxidise ferrous iron to the ferric form so transferrin can carry it. Without adequate copper, iron accumulates in tissue stores and is not mobilised for use, no matter how much iron is supplied. This is textbook trace-mineral biochemistry, not a formulation theory.
Lysyl oxidase is a copper-dependent enzyme that oxidises specific lysine residues in collagen and elastin, and those oxidised residues then form the covalent crosslinks that give connective tissue its tensile strength. Lysine is the substrate and copper is the cofactor, so both are required for normal crosslinking. Neither substitutes for the other.
Supplemental collagen peptides supply amino acids for new collagen synthesis, but the crosslinking that stabilises that collagen runs through copper-dependent lysyl oxidase. A formula supporting normal connective tissue has a mechanistic reason to carry copper alongside the peptides. The mechanism is settled; the size of any effect on tissue is a separate question.
A small exchangeable fraction of plasma copper travels bound to histidine and to albumin rather than to ceruloplasmin, and copper-histidine complexes are the recognised low-molecular-weight carrier form. Histidine also chelates copper directly in solution, which matters for stability in a liquid formula. High supplemental histidine can shift how copper distributes between carriers.
Cytochrome c oxidase, complex IV, holds two copper centres and is the terminal step of the electron transport chain; coenzyme Q10 shuttles electrons into that chain at complex III. Copper deficiency lowers complex IV activity directly. The two act at different points in one pathway, which is a shared-pathway relationship rather than an additive dose effect.
Reduced lipoic acid carries two thiol groups and forms complexes with divalent transition metals including copper. In a combined formula that binding happens in the tablet and in the gut, not only after absorption. The interaction is a real formulation consideration and is often ignored in multi-ingredient products.
Quercetin chelates copper through its catechol and carbonyl groups, and copper-quercetin complexes behave differently from either component alone. Free copper plus a reducing polyphenol also drives Fenton-type redox chemistry that can generate radicals rather than quench them, so the pairing is not simply two antioxidants together. This is a reason to keep the two apart in a liquid or to keep the copper as a defined complex.
Catechin galloyl groups bind copper and iron tightly, which is why strong tea reduces mineral absorption when taken with a meal. The same chemistry applies to a copper salt in a formula. Timing separation, rather than reformulation, is usually what resolves it.
Free copper cycles between its two oxidation states and catalyses the propagation of lipid peroxidation in oils and in membranes. Tocopherols interrupt that chain reaction. In an oil-containing product this matters for shelf life as much as for physiology, which is why copper salts and unprotected oils are a stability question.
Fermentation of inulin lowers colonic pH and keeps divalent minerals in solution further along the gut, which is the accepted mechanism behind fibre effects on mineral absorption. Most of that work measured calcium and magnesium rather than copper. The mechanism is general to divalent minerals; the copper-specific evidence is thinner.
Viscous soluble fibre traps divalent cations in its gel matrix and slows their contact with the absorptive surface. Taken together with a copper salt it reduces how much copper is picked up from that dose. A gap of a couple of hours is the usual practice.
Any meaningful zinc load induces metallothionein in the intestinal lining, and metallothionein binds copper more tightly than zinc, so the copper stays in the shed enterocyte and leaves in the stool. Zinc carnosine delivers zinc and does this the same way an ordinary zinc salt does. The relationship is dose-dependent and well characterised.
Divalent metal transporter 1 carries several divalent cations, so a large iron dose in the same window reduces the uptake of others sharing that route. Chelated iron forms are absorbed partly by a different path, which softens but does not remove the overlap. Splitting a high-dose iron from a copper-containing product is the practical response.
Copper and zinc together form the metal centre of cytosolic superoxide dismutase, which converts superoxide into hydrogen peroxide; selenium-dependent glutathione peroxidase then removes that hydrogen peroxide. The two enzymes sit in sequence, so a shortfall in either mineral leaves an intermediate accumulating. The sequence is established; a supplementation benefit of pairing them in people with adequate intake is not.
Talk to a doctor before taking Copper Sulfate if any of these apply to you: Excess copper is toxic (upper limit 10mg/day), Can cause nausea at higher doses, People with Wilson's disease must avoid copper supplements, Competes with zinc for absorption. These are flags to check first, not effects Copper Sulfate is known to cause.
Not medical advice. Show the label to your pharmacist.The whole-food sources on file. A supplement closes the gap, it does not replace dinner.
A gram-for-gram figure (how much of each you would eat to match a dose) will appear here once it is sourced and reviewed. This page will not print a number it cannot cite.
Copper Sulfate is the sulfate form of Copper. Same mineral, bound to a different partner, so absorption and feel differ from form to form.
These are the studies our verdict leans on, chosen from the 5 we read for Copper Sulfate. The full linked list is below.
2 sources behind our Copper Sulfate verdict: peer-reviewed studies and registered clinical trials. Every one links straight to PubMed, the journal, or ClinicalTrials.gov. Read them yourself.
Evidence surfaced via Semantic Scholar (Allen Institute for AI) and ClinicalTrials.gov. Ranked by study type and citation weight, not cherry-picked.
Read this carefully. These are 466 voluntary, unverified reactions reported to the FDA (openFDA). The number mostly reflects how popular Copper Sulfate is, not how risky it is. A report is not proof Copper Sulfate caused anything. It is a signal of what to watch for, nothing more.
Source: openFDA adverse-event reports. Voluntary reporting, not an incidence rate.
FDA Disclaimer: These statements have not been evaluated by the Food and Drug Administration. This information is for educational purposes only and is not intended to diagnose, treat, cure, or prevent any disease. Consult your healthcare provider before starting any supplement regimen.